- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on METASTATIC NON-SMALL CELL LUNG CANCER in Argentina
Total 173 results
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerUnited States, Australia, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, United Kingdom, Philippines, China, Germany, Norway, Canada, Hong Kong, Argentina, Netherlands, Taiwan, India, Thailand, Indonesia, Denmark
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingNon Small Cell Lung CancerUnited States, China, Hungary, Brazil, Argentina, Canada, France, Greece, Italy, Japan, Korea, Republic of, Romania, Spain, Taiwan, Turkey
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Germany, Spain, Japan, Canada, France, Korea, Republic of, Italy, United Kingdom, China, Taiwan, Hungary, Singapore, Switzerland, Netherlands, Brazil, Mexico, Russian Federation, Puerto Rico, Poland, Hong Kong, Romania and more
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non-small Cell Lung CancerVietnam, United States, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, Turkey, Germany, China, Japan, Netherlands, Argentina, Austria, Belgium, Canada, Portugal, Greece, India, Denmark, Malaysia, Indonesia, Thailand, Singapore
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Spain, Hong Kong, Argentina, China, Netherlands, France, Brazil, Belgium, Canada, Germany, Greece, Italy, Japan, Turkey, Ukraine
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Israel, Italy, Spain, Hong Kong, Taiwan, Canada, France, Greece, Russian Federation, Czech Republic, Australia, Bulgaria, Germany, Thailand, Hungary, United Kingdom, Argentina, Brazil, Poland
-
Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)Russian Federation, United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Greece, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Puerto Rico, Romania, Spain, Sweden, Swit... and more
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
OSI PharmaceuticalsCompletedNon-small Cell Lung CancerUnited States, Hungary, Spain, Taiwan, Korea, Republic of, Italy, United Kingdom, Canada, Australia, Belgium, Germany, Austria, Poland, Romania, Argentina, France, Czech Republic, Greece, Russian Federation
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerUnited States, Sweden, Australia, Czech Republic, France, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, Germany, China, Poland, Romania, Denmark, Hong Kong, Canada, Austria, Belgium, Hungary, Israel, Nether... and more
-
AbbVieRecruitingNon Small Cell Lung CancerUnited States, Argentina, Brazil, Bulgaria, Chile, Czechia, Greece, Italy, Japan, Korea, Republic of, Netherlands, Poland, Romania, Spain, Taiwan, Turkey, Australia, France, Belgium, China, Austria, United Kingdom, Germany, South Africa, Mexi... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Austria, Denmark, Italy, Spain, Germany, Mexico, Netherlands, Japan, Brazil, Greece, Argentina, Slovakia, Lebanon, Belgium, Oman, United Arab Emirates
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, United Kingdom, Australia, Belgium, Brazil, Canada, China, Portugal, Spain, France, Germany, Poland, Hong Kong, Israel, Thailand, Turkey, Japan, Austria, Hungary, Italy, Taiwan, Netherlands, Greece, New... and more
-
Hoffmann-La RocheCompletedSquamous Non-Small Cell Lung CancerUnited States, Spain, France, Australia, Germany, Taiwan, Canada, Argentina, Belgium, Singapore, Brazil, Netherlands, Israel, Portugal, Russian Federation, Japan, Italy, Chile, Latvia, Peru, Ukraine, Lithuania, Slovakia, Bulgaria, Mexico, Austri...
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, Czechia, Italy, Portugal, Hong Kong, Thailand, Singapore, Bulgaria, Turkey, Argentina, Belgium, G... and more
-
AstraZenecaCompletedDiagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (IDENTIFY)Non-Small Cell Lung Cancer | Stage IIIB/IVArgentina
-
BayerCompletedCarcinoma | Non-Small-Cell LungItaly, Spain, China, Korea, Republic of, Bulgaria, Turkey, Greece, Philippines, Taiwan, Russian Federation, Hungary, Singapore, France, Netherlands, Sweden, Belgium, United States, Austria, Thailand, Germany, Israel, Poland, Canada, United... and more
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium
-
BayerNot yet recruitingAdvanced Non-small Cell Lung Cancer | HER2 MutationUnited States, China, Korea, Republic of, Belgium, Hong Kong, Japan, Taiwan, Denmark, Germany, Israel, Poland, Italy, United Kingdom, Bulgaria, Czechia, Portugal, Switzerland, Greece, Turkey, Romania, Sweden, France, Singapore, Mexico, ... and more
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada
-
Nereus Pharmaceuticals, Inc.CompletedCancerUnited States, Australia, India, Chile, Brazil, Argentina
-
Gilead SciencesArcus Biosciences, Inc.RecruitingNon-small Cell Lung CancerTaiwan, Hong Kong, United States, Netherlands, United Kingdom, Italy, Korea, Republic of, Spain, Israel, Japan, France, Portugal, China, Turkey, Brazil, Mexico, Austria, Germany, Belgium, Chile, Argentina, Singapore, Canada
-
AstraZenecaRecruitingCarcinoma | Non-Small-Cell LungChina, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Malaysia, Argentina, Hong... and more
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Australia, Brazil, China, United Kingdom, Israel, Belgium, Netherlands, Argentina, Spain, Taiwan, Canada, Italy, Poland, Turkey, Sweden, Switzerland
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, Korea, Republic of, Taiwan, France, Spain, Italy, United States, Germany, Romania, Poland, Brazil, Chile
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, Spain, United States, France, Taiwan, Italy, China, Argentina, Australia, Malaysia, Canada, Japan, Chile
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerSpain, Argentina, China, France, Turkey, Brazil, Korea, Republic of, Mexico, Chile, Guatemala, Peru, Thailand, Costa Rica, United Kingdom, New Zealand, Hungary, Latvia, Russian Federation, South Africa, Ukraine, Italy, Greece, Poland
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States, Spain, China, Italy, Turkey, Argentina, United Kingdom, Canada, Germany, Brazil, Vietnam, Thailand, Poland, Russian Federation, Japan, Korea, Republic of, Taiwan, Malaysia, Singapore, Romania
-
Novartis PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerChina, Croatia, Taiwan, Greece, Canada, Thailand, Lebanon, Australia, Hong Kong, Slovenia, Spain, Jordan, Korea, Republic of, Romania, Italy, Hungary, India, Turkey, Portugal, Argentina, Malaysia, Colombia, Iceland, Vietnam, Mexico, United... and more
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Belgium, China, France, Netherlands, Japan, Hungary, Russian Federation, Taiwan, Ireland, Romania, Israel, Latvia, Italy, Portugal, Austria, Bulgaria, Chile, Ukraine, Argenti... and more
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States, Greece, Hong Kong, Taiwan, Argentina, Germany, United Kingdom, Singapore, Italy, Spain, France, Korea, Republic of, Netherlands, Brazil, Canada, Turkey, China, New Zealand, Hungary, Poland, Australia, Japan, Israel, Bel... and more
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Canada, Thailand, Vietnam, France, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, Russian Federation, China, Taiwan, United Kingdom, Czechia, Chile, Australia, Argentina, Slovakia, South Africa
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingNon-Small Cell Lung CancerChina, Spain, Canada, Israel, Italy, Japan, Korea, Republic of, Taiwan, Australia, Poland, Brazil, Turkey, Belgium, Singapore, Czechia, Romania, Germany, Russian Federation, Greece, Netherlands, Argentina, France, Hong Kong, Mexico, Ukr... and more
-
Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung CancerItaly, United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Ireland, Japan, Mexico, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Belgium, Israel, Sweden, China, Hong Kong, Australia, Colombia, Romania, Germany, Ireland, Mexico, Korea, Republic of, Taiwan, Turkey, Russian Federation, Czech Republic, Hungary, Netherlands, New Zealand, Peru, Finland, Austria and more
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerCanada, Belgium, Brazil, China, Denmark, Portugal, Spain, United Kingdom, Argentina, Bulgaria, Colombia, Germany, India, Ireland, Italy, Luxembourg, Mexico, Poland, Romania, Slovakia, Switzerland, Vietnam, Kazakhstan, Czechia
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerBelgium, Italy, Spain, United States, Poland, India, Taiwan, Thailand, Vietnam, Canada, France, Germany, Korea, Republic of, Brazil, Hungary, Japan, Mexico, Peru, Philippines, Russian Federation, China, Austria, Chile, Netherlands, Bulg... and more
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, France, Spain, Italy, Belgium, Korea, Republic of, United States, Mexico, Hungary, Sweden, Turkey, Ireland, Greece, Russian Federation, Germany, Netherlands, Bulgaria, Romania, Brazil, United Kingdom, Poland, Australia, C... and more
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerCanada, Belgium, Korea, Republic of, United States, France, Brazil, China, New Zealand, Israel, Spain, Argentina, Serbia, Mexico, Italy, Japan, Turkey, Taiwan, Costa Rica, Thailand, Australia, Germany, Hong Kong, Netherlands, Peru, Poland, Russian Federation and more
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLung CancerFrance, Spain, Australia, United States, Sweden, Belgium, Switzerland, Italy, Egypt, South Africa, Israel, Colombia, Morocco, Norway, Greece, Brazil, Poland, Argentina, Austria, Chile, Czech Republic, Former Yugoslavia, Japan, Lithuania, Macedonia, The Former Yugoslav Republic... and more
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
NCIC Clinical Trials GroupPfizerCompletedLung CancerTaiwan, Canada, Australia, Italy, New Zealand, United States, Thailand, Korea, Republic of, Brazil, Argentina, Philippines, Peru
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, Hungary, Australia, Brazil, Canada, Spain, Germany, United Kingdom, Chile, Israel, Italy, Netherlands, Argentina, Ukraine, Russian Federation